日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

  1. Home
  2. 抗體
  3. 科研級生物類似抗體
  4. CALCRL (Erenumab Biosimilar) Recombinant Monoclonal Antibody

CALCRL (Erenumab Biosimilar) Recombinant Monoclonal Antibody

  • 貨號：
    CSB-RA614981MB1HU
  • 規(guī)格：
    ￥83486
  • 其他：

產(chǎn)品詳情

  • 產(chǎn)品描述：
    CALCRL (Erenumab Biosimilar Antibody)重組單克隆抗體是一種針對降鈣素基因相關肽受體（CALCRL）的生物制劑，主要用于科研領域的生物學機制研究。該抗體通過基因工程技術(shù)制備，具有高度的靶向性和生物活性，能夠特異性結(jié)合CALCRL受體，從而為研究該受體在神經(jīng)系統(tǒng)、心血管系統(tǒng)及炎癥反應中的生理與病理作用提供重要工具。 在結(jié)構(gòu)上，該重組單克隆抗體采用單克隆抗體的典型結(jié)構(gòu)，包含重鏈和輕鏈可變區(qū)，可與CALCRL受體的特定抗原表位高效結(jié)合，其結(jié)合親和力和特異性經(jīng)過優(yōu)化，適用于體外實驗和動物模型研究。通過抑制或激活CALCRL受體信號通路，研究人員可深入探索其在偏頭痛、疼痛感知、血管調(diào)節(jié)等生理過程中的分子機制，為相關疾病的發(fā)病機理研究提供實驗依據(jù)。 作為科研用試劑，該抗體可廣泛應用于、受體結(jié)合實驗及功能性分析等多種實驗方法。其穩(wěn)定的生物學活性和批次間一致性，能夠確保實驗結(jié)果的可靠性和可重復性。此外，該抗體的研發(fā)為靶向CALCRL受體的藥物篩選和開發(fā)提供了重要的研究基礎，有助于推動相關治療策略的探索與優(yōu)化。 在使用過程中，需嚴格按照科研實驗規(guī)范進行操作，根據(jù)具體實驗需求選擇合適的抗體濃度和反應條件，以確保實驗數(shù)據(jù)的準確性。該產(chǎn)品僅用于實驗室研究，不可用于臨床診斷或治療用途。
  • Uniprot No.：
  • 基因名：
  • 別名：
    Aimovig research-grade biosimilar; AMG 334 research-grade biosimilar; AMG-334 research-grade biosimilar; erenumab research-grade biosimilar; erenumab research-grade biosimilar; Erenumab (Genetical Recombination) research-grade biosimilar; erenumab (r-INN) research-grade biosimilar; Erenumab-AOOE research-grade biosimilar; I5I8VB78VT (UNII code) research-grade biosimilar ;CALCRL antibody; CGRPR antibody; Calcitonin gene-related peptide type 1 receptor antibody; CGRP type 1 receptor antibody; Calcitonin receptor-like receptor antibody; CRLR antibody
  • 反應種屬：
    Human
  • 免疫原：
    Recombinant Human CALCRL protein
  • 免疫原種屬：
    Homo sapiens (Human)
  • 標記方式：
    Non-conjugated
  • 克隆類型：
    Monoclonal
  • 濃度：
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液：
    0.01M PBS，pH7.4
  • 產(chǎn)品提供形式：
    Liquid
  • 應用說明：
    Validation Status
    Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
    Guaranteed Quality
    ① Antibody purity?> 95% tested by SDS-PAGE.
    ② Endotoxin level < 0.1EU/ug tested by LAL method.
  • 儲存條件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期：
    3-4 weeks
  • 用途：
    It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.

產(chǎn)品評價

靶點詳情

  • 功能：
    Receptor for calcitonin-gene-related peptide (CGRP) together with RAMP1 and receptor for adrenomedullin together with RAMP3. Receptor for adrenomedullin together with RAMP2. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.
  • 基因功能參考文獻：
    1. Single nucleotide polymorphism of CRLR is associated with Stroke. PMID: 28904253
    2. These findings confirm the role of the stalk region in peptide binding but also provide further evidence that G protein-coupled receptor (GPCR) and adrenomedullin interact differently with CLR, with CGRP forming closer contacts with the stalk than adrenomedullin. PMID: 29388762
    3. This study revealed for the first time an increase of mast-nerve association and CGRPR expression on mast cells during AR as well as nerve fibres containing receptors for mast cells. PMID: 28030866
    4. Data suggest CGRP receptor (CGRPR) ECL2 (extracellular loop 2 domain) enables interaction with N-terminal residues of CGRP; this provides evidence for dual involvement of ECL2 in two-domain binding model of CGRP/CGRPR interaction; CGRPR is obligate heterodimer of CLR/RAMP1. (CGRP = calcitonin gene-related peptide; CLR = calcitonin receptor-like receptor; RAMP1 = receptor [calcitonin] activity modifying protein 1) PMID: 28691801
    5. Mouse and human heart valves expressed mRNAs for the CRL ligands adrenomedullin (AM), adrenomedullin-2 (AM-2) and calcitonin gene-related peptide (CGRP) and for their receptor components, i.e., CRL and receptor-activity-modifying proteins 1-3. PMID: 27553639
    6. interaction of RAMP2 or RAMP3 with CLR induces conformational variation in the juxtamembrane region, yielding distinct binding pockets, probably via an allosteric mechanism. PMID: 27013657
    7. STC1 interferes with CALCRL signaling during osteoblastogenesis via adenylate cyclase inhibition. PMID: 25591908
    8. Data suggest that ligand binding of a G protein-coupled receptor (GPCR) may inform drug development targeting calcitonin receptor-like receptor (CLR):receptor activity-modifying proteins RAMP1/2 complexes. PMID: 25982113
    9. the AM system is widely expressed in human thymus from newborns; both AM1 receptor components CLR and RAMP2, but not RAMP3, are not associated with the plasma membrane of TECs and thymocytes but are located intracellularly, notably in the nucleus PMID: 24831942
    10. Two CALCRL variants were associated with risk for gestational diabetes. PMID: 23797962
    11. Data suggest isoforms of RAMP (receptor activity-modifying protein) modulate accessibility of peptides to residues situated on CALCRL N-terminal domain; RAMP3/RAMP2/RAMP1 appear to alter accessibility of specific residues at CALCRL-RAMP interface. PMID: 24199627
    12. CRLR expression is upregulated in the fetal lung with increasing gestational age. PMID: 24169318
    13. The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis. PMID: 23969937
    14. An alanine scan of residues 271-294 of CLR showed that the ability of CGRP to produce cAMP was impaired by point mutations at 13 residues; most of these also impaired the response to adrenomedullin (AM). PMID: 24047872
    15. The study implicates genetic variation at the CALCRL gene in the pathogenesis of primary angle closure glaucoma in an Australian Caucasian cohort. PMID: 22933837
    16. CLR and RAMP1 co-localize in the enteric nervous system of the stomach, ileum and colon, and are in close proximity to their ligands CGRP and IMD PMID: 22484227
    17. This study showed that CLR immunoreactivity was observed in satellite glial cells (SGCs) as well as in nerve fibers, but not in neurons. PMID: 22208649
    18. human CLR ECL3 is crucial for adrenomedullin (AM)-induced cAMP responses via three CLR/RAMP heterodimers, and activation of these heterodimers probably relies on AM-induced conformational changes PMID: 22142144
    19. The CRLR-RAMP2 interactions were confirmed for the full-length proteins on the cell surface by site-specific photo-crosslinking. PMID: 22102369
    20. Unexplained infertility was characterised by lower number of vessels stained with CRLR in endometrium compared to fertile controls. PMID: 20954838
    21. Extracellular loops 1 and 3 and their associated transmembrane regions of the calcitonin receptor-like receptor are needed for CGRP receptor function. PMID: 21703310
    22. Structure-function analysis of helix 8 of human calcitonin receptor-like receptor within the adrenomedullin 1 receptor PMID: 20946927
    23. Data describe the role of residues 23-60 of the calcitonin receptor-like receptor in binding with interaction sites within the N-terminus of the calcitonin gene-related peptide receptor. PMID: 19913063
    24. the hCRLR C-tail is crucial for adrenomedullin-evoked cAMP production and internalization of the CRLR/RAMP2, while the receptor internalization is dependent on the aforementioned GPCR kinases, but not Gs coupling. PMID: 20074556
    25. Intrinsic cardiac adrenergic cells constitute a delta-opioid-regulated adrenopeptidergic paracrine system conferring robust cardioprotection through beta(2)-AR/CGRP-R co-signalling. PMID: 19581316
    26. Activation of calcitonin receptor and calcitonin receptor-like receptor by membrane-anchored ligands. PMID: 19903822
    27. Receptor activity modifying proteins interaction with human and porcine calcitonin receptor-like receptor (CRLR) in HEK-293 cells PMID: 11693189
    28. This study aimed to identify the cellular location of calcitonin receptor-like receptor (CRLR) which is pharmacologically identical to CGRP receptor-1, a putative molecular target of CGRP and adrenomedullin PMID: 11814625
    29. The CGRP receptor components, RAMP1 and CRLR, are down-regulated during myeloid differentiation of CD34+ cells, and CGRP receptor selectively promotes the development of CFU-GM. PMID: 11937264
    30. results show the presence of calcitonin receptor-like receptor and receptor activity-modifying proteins in middle meningeal, middle cerebral, pial, and superficial temporal vessels PMID: 11973435
    31. expression at the human implantation site PMID: 12213903
    32. receptor activity-modifying protein 1 binds to the CRLR PMID: 12574158
    33. Cysteine residues in the extracellular loops of hCRLR and in the extracellular domain of hRAMP2 thus appear to play distinct roles in the cell surface expression and function of the receptor heterodimer. PMID: 12630808
    34. findings show that human skin keratinocytes and fibroblasts express adrenomedullin and its receptors L1-R and CRLR PMID: 12684703
    35. Transcriptional regulation of the CRLR gene in microvascular endothelial cells by hypoxia. PMID: 12824306
    36. TNF-alpha induced time- and dose-dependent decreases in the expression of CRLR mRNA in cultured human coronary artery smooth muscle cells, thereby diminishing AM-evoked cAMP production PMID: 15245870
    37. Results demonstrated in the atria of heart failure patients there is an up-regulation of CGRP receptor by an increase of RAMP1 in association with CRLR. PMID: 15300632
    38. novel function for RAMP3 in the post-endocytic sorting of the calcitonin receptor-like receptor. PMID: 15613468
    39. The N-terminal domain of calcitonin receptor-like receptor is an autonomously folded unit possessing a well-defined structure and is significantly involved in ligand binding and specificity. PMID: 15641806
    40. among women, the T allele of the SNP rs696574 (C --> T, in intron 6) was significantly more frequent in essential hypertension subjects PMID: 15797661
    41. Structural and functional characteristics of the CGRP-receptor and of family B G-protein-coupled receptors in general. PMID: 16293613
    42. the respective C-tails of hRAMP2 and -3 differentially affect hCRLR surface delivery and internalization PMID: 16410241
    43. adrenomedullin may prevent or reduce rheumatoid arthritis-fibroblast-like synoviocyte apoptosis, via up-regulation of its functional receptor CRLR/receptor activity-modifying protein-2 PMID: 16622024
    44. Results will facilitate structural analysis of the recombinant protein will facilitate structural analysis of human RCP (receptor component protein), and allow further understanding of RCP function PMID: 17067815
    45. CLR and RAMP1 traffic from endosomes to lysosomes by ubiquitin-independent mechanisms, where they are degraded at different rates PMID: 17310067
    46. A mutated RAMP1 that cannot reach the cell surface, even in the presence of CRLR, indicating that the deficient targeting resulted from the altered conformation of the complex. PMID: 17503773
    47. HRS mediates post-endocytic trafficking of protease-activated receptor 2 and calcitonin receptor-like receptor PMID: 17675298
    48. Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of RAMP1. PMID: 17785463
    49. There were some differences in mRNA expression for CL-R (higher) and RAMP3 (lower) in middle cerebral artery compared to coronary artery and pulmonary artery. PMID: 18198792
    50. findings provided no significant linkage or association of adrenomedullin and CRLR-RAMP-2 genes with rheumatoid arthritis in the studied trio families PMID: 19210874

    顯示更多

    收起更多

  • 亞細胞定位：
    Cell membrane; Multi-pass membrane protein.
  • 蛋白家族：
    G-protein coupled receptor 2 family
  • 組織特異性：
    Predominantly expressed in the lung and heart.
  • 數(shù)據(jù)庫鏈接：

    HGNC: 16709

    OMIM: 114190

    KEGG: hsa:10203

    STRING: 9606.ENSP00000376177

    UniGene: Hs.470882



×
生命科學計算平臺